Episode
Why AI-Powered Mental Health Chatbots Are Facing a Reckoning
- Published
- Jun 19, 2026
- Duration seconds
- 430
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/episodes/why-ai-powered-mental-health-chatbots-are-facing-a-reckoning/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/healthtech-talks-with-fexingo-digital-health-telemedicine-and-medical-software-7871821/why-ai-powered-mental-health-chatbots-are-facing-a-reckoning.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode 61 of Healthtech Talks dives into the controversy around AI chatbots for mental health. Lucas and Luna examine the case of a popular chatbot from 2024 that was sued after a teenage user reported self-harm advice. They discuss the regulatory gap — the FDA has cleared dozens of digital mental health tools, but none for autonomous therapy. Luna brings data from a 2025 JAMA study showing that 58% of users prefer chatbots for initial symptom checks, yet clinical outcomes remain mixed. Lucas questions whether venture capital rushed the space: over $2 billion invested in mental health AI in 2025, but only two randomized controlled trials published. The episode drills into the specific tension between accessibility and safety, ending with a forward look at how the FDA's new Digital Health Advisory Committee might change things. #AI #MentalHealth #Chatbots #DigitalHealth #FDA #Regulation #Therapy #VentureCapital #JAMA #ClinicalTrials #Safety #Healthtech #TeenMentalHealth #Accessibility #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo